Last 12 months
Inside the activity.
34 purchase rows · 105 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 15 |
| Dec 2025 | 0 | 25 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 10 | 25 |
| Apr 2026 | 0 | 3 |
| May 2026 | 22 | 0 |
| Jun 2026 | 2 | 9 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 13 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2025 Filed Jan 6, 2025 23:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 2,654 | $75.47 | $200,306.67 |
DisclosureSEC source: 0001415889-25-000836 · form4-01062025_110139.xml · nonDerivative · entry 1 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,492 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.981 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029770 · form4-12182024_111217.xml · derivative · entry 3 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,772 Underlying: Class A Common Stock · 7,197 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 3,728 | $76.75 | $286,139.28 |
DisclosureSEC source: 0001415889-24-029770 · form4-12182024_111217.xml · nonDerivative · entry 2 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,200 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
Exercise / conversionClass A Common Stock | 7,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029770 · form4-12182024_111217.xml · nonDerivative · entry 1 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 23:22 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029771 · form4-12182024_111215.xml · derivative · entry 3 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,750 Underlying: Class A Common Stock · 18,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 23:22 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 10,501 | $76.75 | $805,994.80 |
DisclosureSEC source: 0001415889-24-029771 · form4-12182024_111215.xml · nonDerivative · entry 2 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,146 F2 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 23:22 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
Exercise / conversionClass A Common Stock | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029771 · form4-12182024_111215.xml · nonDerivative · entry 1 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 00:18 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029015 · form4-12122024_121241.xml · derivative · entry 3 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,697 Underlying: Class A Common Stock · 2,462 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. F4 · derivative.expiration_date: 6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 00:18 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 1,137 | $76.37 | $86,835.87 |
DisclosureSEC source: 0001415889-24-029015 · form4-12122024_121241.xml · nonDerivative · entry 2 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,731 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.37 to $76.8317 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 00:18 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
Exercise / conversionClass A Common Stock | 2,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029015 · form4-12122024_121241.xml · nonDerivative · entry 1 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 00:19 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029016 · form4-12122024_121238.xml · derivative · entry 3 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,372 Underlying: Class A Common Stock · 6,547 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. F4 · derivative.expiration_date: 6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 00:19 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 3,661 | $76.37 | $279,597.53 |
DisclosureSEC source: 0001415889-24-029016 · form4-12122024_121238.xml · nonDerivative · entry 2 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,897 F2 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.37 to $76.6892 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 00:19 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
Exercise / conversionClass A Common Stock | 6,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029016 · form4-12122024_121238.xml · nonDerivative · entry 1 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 00:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 263 | $78.39 | $20,616.89 |
DisclosureSEC source: 0001415889-24-028197 · form4-12042024_121232.xml · nonDerivative · entry 2 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,406 F2 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction. Read SEC document |
| December 01, 2024 Filed Dec 4, 2024 00:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 718 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028197 · form4-12042024_121232.xml · derivative · entry 3 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,021 Underlying: Class A Common Stock · 718 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: 6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: 6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| December 01, 2024 Filed Dec 4, 2024 00:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
Exercise / conversionClass A Common Stock | 718 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028197 · form4-12042024_121232.xml · nonDerivative · entry 1 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 2,108 | $77.40 | $163,165.52 |
DisclosureSEC source: 0001415889-24-027662 · form4-11252024_111101.xml · nonDerivative · entry 9 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,951 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024. F10 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.18 to $77.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 2,711 | $76.41 | $207,149.14 |
DisclosureSEC source: 0001415889-24-027662 · form4-11252024_111101.xml · nonDerivative · entry 8 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,059 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024. F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.07 to $77.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 5,162 | $75.34 | $388,927.28 |
DisclosureSEC source: 0001415889-24-027662 · form4-11252024_111101.xml · nonDerivative · entry 7 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,770 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024. F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 3,839 | $74.97 | $287,791.02 |
DisclosureSEC source: 0001415889-24-027662 · form4-11252024_111101.xml · nonDerivative · entry 6 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,932 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024. F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.418 to $75.27 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 5,524 | $73.79 | $407,608.23 |
DisclosureSEC source: 0001415889-24-027662 · form4-11252024_111101.xml · nonDerivative · entry 5 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,771 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.4107 to $74.3626 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 1,057 | $73.00 | $77,161.53 |
DisclosureSEC source: 0001415889-24-027662 · form4-11252024_111101.xml · nonDerivative · entry 4 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,295 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.3128 to $73.3033 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 969 | $71.86 | $69,629.34 |
DisclosureSEC source: 0001415889-24-027662 · form4-11252024_111101.xml · nonDerivative · entry 3 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,352 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.3076 to $72.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 430 | $70.84 | $30,463.22 |
DisclosureSEC source: 0001415889-24-027662 · form4-11252024_111101.xml · nonDerivative · entry 2 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,321 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.2946 to $71.2846 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 23:21 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 200 | $69.58 | $13,915.00 |
DisclosureSEC source: 0001415889-24-027662 · form4-11252024_111101.xml · nonDerivative · entry 1 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,751 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.16 to $69.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 01:21 UTC |
Ryan JasonDirector
|
SaleClass A Common Stock | 4,272 | $70.50 | $301,184.54 |
DisclosureSEC source: 0001415889-24-027473 · form4-11222024_011124.xml · nonDerivative · entry 7 Ryan Jason · CIK 0001585017 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jason Ryan u/a dtd 11/25/2018 Disclosed balance after: 0 F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.22 to $70.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 01:21 UTC |
Ryan JasonDirector
|
SaleClass A Common Stock | 1,857 | $69.84 | $129,688.98 |
DisclosureSEC source: 0001415889-24-027473 · form4-11222024_011124.xml · nonDerivative · entry 6 Ryan Jason · CIK 0001585017 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jason Ryan Trust u/a dtd 11/25/2018 Disclosed balance after: 4,272 F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.22 to $70.21 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 01:21 UTC |
Ryan JasonDirector
|
SaleClass A Common Stock | 9,361 | $68.36 | $639,875.84 |
DisclosureSEC source: 0001415889-24-027473 · form4-11222024_011124.xml · nonDerivative · entry 5 Ryan Jason · CIK 0001585017 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jason Ryan Trust u/a dtd 11/25/2018 Disclosed balance after: 6,129 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.01 to $68.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2024 Filed Nov 22, 2024 01:21 UTC |
Ryan JasonDirector
|
SaleClass A Common Stock | 774 | $72.26 | $55,926.53 |
DisclosureSEC source: 0001415889-24-027473 · form4-11222024_011124.xml · nonDerivative · entry 4 Ryan Jason · CIK 0001585017 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jason Ryan Trust u/a dtd 11/25/2018 Disclosed balance after: 15,490 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.12 to $72.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2024 Filed Nov 22, 2024 01:21 UTC |
Ryan JasonDirector
|
SaleClass A Common Stock | 24,784 | $71.35 | $1,768,420.19 |
DisclosureSEC source: 0001415889-24-027473 · form4-11222024_011124.xml · nonDerivative · entry 3 Ryan Jason · CIK 0001585017 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jason Ryan Trust u/a dtd 11/25/2018 Disclosed balance after: 16,264 F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.04 to $72.0302 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2024 Filed Nov 22, 2024 01:21 UTC |
Ryan JasonDirector
|
SaleClass A Common Stock | 5,952 | $70.86 | $421,783.72 |
DisclosureSEC source: 0001415889-24-027473 · form4-11222024_011124.xml · nonDerivative · entry 2 Ryan Jason · CIK 0001585017 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jason Ryan Trust u/a dtd 11/25/2018 Disclosed balance after: 41,048 F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.026 to $71.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2024 Filed Nov 22, 2024 01:21 UTC |
Ryan JasonDirector
|
GiftClass A Common Stock | 141,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027473 · form4-11222024_011124.xml · nonDerivative · entry 1 Ryan Jason · CIK 0001585017 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jason Ryan Trust u/a dtd 11/25/2018 Disclosed balance after: 47,000 F1 · ownership.direct: On November 19, 2024, the reporting person transferred 141,356 shares of GeneDx Holdings Corp. Class A common stock from the reporting person's indirect holdings to the Jason Ryan 2024 GRAT (the "GRAT") for no consideration. The reporting person is the trustee of the GRAT, and the reporting person is the sole annuitant of the grantor retained annuity trust. The reporting person remains the beneficial owner of the securities held by the grantor retained annuity trust. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 20:00 UTC |
MOUNT SINAI HEALTH SYSTEM, INC.10% owner
|
SaleClass A Common Stock | 126,782 | $70.78 | $8,973,059.44 |
DisclosureSEC source: 0000950170-24-128961 · ownership.xml · nonDerivative · entry 2 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · CIK 0001883139 · 10% owner MOUNT SINAI HEALTH SYSTEM, INC. · CIK 0001883135 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,719,692 F1 · balance_after: Reflects securities directly held by Icahn School of Medicine at Mount Sinai. The sole member of Icahn School of Medicine at Mount Sinai is Mount Sinai Health System, Inc. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 3,131 | $71.83 | $224,905.37 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 13 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,011 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F14 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.51 to $72.32 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 8,580 | $70.91 | $608,418.10 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 12 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,142 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F13 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.51 to $71.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 6,186 | $70.15 | $433,952.23 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 11 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,722 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F12 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 3,151 | $68.98 | $217,349.36 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 10 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,908 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F11 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.434 to $69.29 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 459 | $67.94 | $31,182.81 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 9 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,059 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F10 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.39 to $68.3863 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 800 | $66.60 | $53,283.04 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 8 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,518 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.36 to $66.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 20:00 UTC |
MOUNT SINAI HEALTH SYSTEM, INC.10% owner
|
SaleClass A Common Stock | 20,359 | $69.78 | $1,420,663.24 |
DisclosureSEC source: 0000950170-24-128961 · ownership.xml · nonDerivative · entry 1 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · CIK 0001883139 · 10% owner MOUNT SINAI HEALTH SYSTEM, INC. · CIK 0001883135 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,846,474 F1 · balance_after: Reflects securities directly held by Icahn School of Medicine at Mount Sinai. The sole member of Icahn School of Medicine at Mount Sinai is Mount Sinai Health System, Inc. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 60 | $74.34 | $4,460.33 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 7 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,318 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.3229 to $74.3571 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 1,510 | $73.71 | $111,301.95 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 6 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,378 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.2478 to $74.0809 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 2,043 | $72.95 | $149,044.61 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 5 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,888 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.2395 to $73.23 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 1,958 | $71.49 | $139,976.83 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 4 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,931 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.2203 to $72.1711 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 7,240 | $70.72 | $511,984.56 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 3 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,889 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.21 to $71.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 4,800 | $69.67 | $334,439.04 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 2 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,129 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.19 to $70.10 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 00:05 UTC |
Stueland KatherineDirector · Chief Executive Officer
|
SaleClass A Common Stock | 5,497 | $68.65 | $377,386.09 |
DisclosureSEC source: 0001415889-24-027270 · form4-11202024_121138.xml · nonDerivative · entry 1 Stueland Katherine · CIK 0001689575 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,929 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.18 to $69.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 17:01 UTC |
MOUNT SINAI HEALTH SYSTEM, INC.10% owner
|
SaleClass A Common Stock | 865,800 | $75.00 | $64,935,000.00 |
DisclosureSEC source: 0000950170-24-120867 · ownership.xml · nonDerivative · entry 1 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · CIK 0001883139 · 10% owner MOUNT SINAI HEALTH SYSTEM, INC. · CIK 0001883135 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,866,833 F1 · balance_after: Reflects securities directly held by Icahn School of Medicine at Mount Sinai. The sole member of Icahn School of Medicine at Mount Sinai is Mount Sinai Health System, Inc. All share amounts presented in this report reflect the 33:1 reverse stock split of the Issuer's Class A common stock effective May 4, 2023. Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 21:14 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 753 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-025838 · form4-10312024_091002.xml · derivative · entry 3 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,520 Underlying: Class A Common Stock · 753 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: 25% of the underlying shares each vested on April 29, 2023 and April 29, 2024, and 6.25% vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: 25% of the underlying shares each vested on April 29, 2023 and April 29, 2024, and 6.25% vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 21:14 UTC |
Feeley KevinCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 274 | $66.60 | $18,248.40 |
DisclosureSEC source: 0001415889-24-025838 · form4-10312024_091002.xml · nonDerivative · entry 2 Feeley Kevin · CIK 0001944119 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,951 F2 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.